ArticleThe oncologist2012

Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer.

Thomas Delate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.